www.cumberlandpharma.com Open in urlscan Pro
184.106.55.64  Public Scan

Form analysis
1 forms found in the DOM

POST /

<form action="/" method="post" id="search-block-form" accept-charset="UTF-8">
  <div>
    <div class="container-inline">
      <h2 class="element-invisible">Search form</h2>
      <div class="form-item form-type-textfield form-item-search-block-form">
        <label class="element-invisible" for="edit-search-block-form--2">Search </label>
        <input title="Enter the terms you wish to search for." onblur="if (this.value == '') {this.value = 'Search';}" onfocus="if (this.value == 'Search') {this.value = '';}" type="text" id="edit-search-block-form--2" name="search_block_form"
          value="Search" size="30" maxlength="128" class="form-text">
      </div>
      <div class="form-actions form-wrapper" id="edit-actions"><input type="submit" id="edit-submit" name="op" value="" class="form-submit"></div><input type="hidden" name="form_build_id" value="form-t1QAKkkGeGF5_6QqtSqXR5ZsqDenK972ykJDhb6ODqo">
      <input type="hidden" name="form_id" value="search_block_form">
    </div>
  </div>
</form>

Text Content

SEARCH FORM

Search



 * ABOUT US
   
   
    * PROFILE & MISSION
   
   
    * OUR STRATEGY
   
   
    * LEADERSHIP TEAM
   
   
    * COMPANY HISTORY


 * OUR PRODUCTS


 * CUMBERLAND EMERGING TECHNOLOGIES


 * INVESTOR RELATIONS
   
   
    * CORPORATE UPDATE
   
   
    * CORPORATE GOVERNANCE
      
      * Board of Directors
      * Management
      * Committees
      * Contact the Board
   
   
    * STOCK INFORMATION
      
      * Historic Stock Lookup
      * Analyst Coverage
      * Ownership Profile
   
   
    * FINANCIAL INFORMATION
      
      * SEC Fillings
      * Annual Reports
      * Quarterly Results
      * Key Ratios
   
   
    * EVENTS & PRESENTATIONS
   
   
    * INVESTOR FAQ'S
   
   
    * NEWS RELEASES
      
      * Press Releases
      * Corporate Updates
      * In the News
   
   
    * CONTACT IR


 * NEWS


 * BLOG


 * CONTACT US
   
   
   CORPORATE HEADQUARTERS
   
   Cumberland Pharmaceuticals Inc.
   1600 West End Avenue, Suite 1300
   Nashville, TN 37203
   
    
   
   Phone: (615) 255-0068
   Toll Free: (877) 484-2700
   Fax: (615) 255-0094
   
   info@cumberlandpharma.com
   
   *For directions to us, please see Location
   
   
   EMPLOYMENT OPPORTUNITIES
   
   employment@cumberlandpharma.com
   
   
   INVESTOR RELATIONS
   
   investors@cumberlandpharma.com
   
   
   BUSINESS DEVELOPMENT
   
   development@cumberlandpharma.com
   
   
   WHOLESALER CUSTOMER SERVICE
   
   Phone: (877) 274-7200
   Fax: (614) 652-9127
   
   
   MEDICAL INFORMATION
   
   This website is not for medical emergencies. If you are a patient, caregiver
   or healthcare professional and need product related information, please visit
   our Products page, which will link you to product-specific websites.
   
   
   ADVERSE EVENT REPORTING
   
   Toll Free Phone: (877) 484-2700
   (For healthcare professionals only)
   
    
   
    
   
   


IMPROVING CARE

Cumberland Pharmaceuticals is on a mission to improve patient care through the
delivery of high-quality pharmaceutical products.

Learn More About Our Products


QUALITY PRODUCTS

Vibativ is an FDA-approved treatment for certain serious bacterial infections
with proven efficacy against difficult-to-treat Gram-positive infections.

Learn More About Our Products


PROVIDING SOLUTIONS

Caldolor is the first injectable approved in the U.S. to manage pain in adults
and pediatric patients and has been shown to help reduce the need for opioids.

Learn More About Our Products


SUPPORTING PATIENTS

Kristalose is the only prescription laxative product available in a powder
formulation.

Learn More About Our Products


EXPANDING OUR PIPELINE

With the addition of our Phase II candidate for patients with Duchenne muscular
dystrophy, we are developing new medicines for the future.

Learn More About Our Products


CORPORATE SUSTAINABILITY

We support our mission through

community involvement, ethical marketing,

drug safety policies and more. 

 

View Sustainability Report


 * 1
 * 2
 * 3
 * 4
 * 5
 * 6

Learn more about recent company developments from Cumberland Pharmaceuticals’
Founder and Chief Executive Officer A.J. Kazimi.

Read Message


RECENT NEWS

November 8, 2022
Cumberland Pharmaceuticals Reports 41% Revenue Growth
November 1, 2022
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE THIRD QUARTER 2022 FINANCIAL RESULTS
View All



CPIX (COMMON STOCK)

Exchange:
NASDAQ

Open:
2.08

Price:
2.11

Change:
-0.13 (5.59%)

Volume:
1,904

Data as of Friday 12/23/2022 04:00 PM E.T.
Minimum 20 minute delay

©Cumberland Pharmaceuticals Inc. 1600 West End Avenue, Suite 1300, Nashville, TN
37203

...

ESG ReportSite MapPrivacy PolicyTerms & ConditionsExpanded Patient Access Policy